Sort
48,018 grants matching “immunotherapy”
Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance
$992,049Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · R35 · FY2023 · CA
Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance
$992,049Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · R35 · FY2022 · CA
PEDIATRIC AIDS CLINICAL TRIAL UNIT
$991,911Univ Of Massachusetts Med Sch Worcester · U01 · FY2004 · AI
Leadership, Planning and Evaluation
$991,761Caryn Lerman · University Of Southern California · P30 · FY2025 · CA
Point-of-care antimicrobial susceptibility testing based on simultaneous tracking of multi-phenotypic features of single bacterial cells
$991,540Shaopeng Wang · Arizona State University-Tempe Campus · R01 · FY2019 · AI
Point-of-care antimicrobial susceptibility testing based on simultaneous tracking of multi-phenotypic features of single bacterial cells
$991,540Shaopeng Wang · Arizona State University-Tempe Campus · R01 · FY2020 · AI
Development of Recombinant Toxins to Treat Hematologic Malignancies
$991,402Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Microglia-Amyloid interactions in delirium superimposed on dementia
$991,397Niccolo Terrando · Duke University · R01 · FY2023 · AG
A single-cell device to capture and analyze rare T-cells from solid tumors.
$991,227Timothy S McConnell · Isoplexis, Inc. · R44 · FY2017 · CA
Elucidating and Targeting tumor dependencies and drug resistance determinants at the single cell level
$991,182Andrea Califano · Columbia University Health Sciences · U01 · FY2022 · CA
Adjuvanted DNA Vaccine for Immunotherapy HIV Infection
$991,097Powderject Vaccines, Inc. · P01 · FY2001 · AI
Therapeutic Antibodies for CMV
$990,935Lawrence Michael Kauvar · Trellis Bioscience, Inc. · R44 · FY2014 · AI
Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging
$990,912Robert A Salata · Case Western Reserve University · U54 · FY2021 · CA
Therapeutic Antibodies for CMV
$990,877Lawrence Michael Kauvar · Trellis Bioscience, Inc. · R44 · FY2015 · AI
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
$990,771Michael T Barrett · Binary Genomics, Inc. · R44 · FY2024 · CA
AGING AS A SELECTIVE PRESSURE THAT DRIVES TUMOR PROGRESSION
$990,450Ana Da Silva Gomes · H. Lee Moffitt Cancer Ctr & Res Inst · DP2 · FY2024 · AG
Dissecting the enhancer logic governing immune cell fate decisions
$990,000Debattama Rai Sen · Massachusetts General Hospital · DP2 · FY2025 · AI
Reducing Cancer Health Disparities in Detroit
$989,994Ann G Schwartz · Wayne State University · P20 · FY2022 · CA
Pathogenesis and Treatment of Anaphylaxis
$989,897Melody C Carter · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Searching for the Goldilocks Zone of Innate Immunity in Alzheimer's Disease
$989,879Todd E. Golde · Emory University · R01 · FY2025 · AG
PROGRAM PROJECT IN ALLOGENEIC STEM CELL TRANSPLANTATION
$989,863Dana-Farber Cancer Institute · P01 · FY2000 · AI
Liver Cancer Program
$989,424Anuradha Budhu · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Development of synthetic sphingolipids for prostate cancer therapy
$989,405Alison Nicole McCracken · Siege Pharmaceuticals, Inc. · R44 · FY2021 · CA
Clinical Analysis Of Disorders Of Hearing And Balance
$989,366Carmen Crowell Brewer · National Institute On Deafness And Other Communication Disorders · ZIA · FY2011 · DC
Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
$989,275Scarlett L Gomez · University Of California, San Francisco · R01 · FY2024 · CA